Keywords: copaxone, betaseron, effective, avonex, results, significant, says
Copaxone, Betaseron effective, Avonex results not significant, says study
Article | 14 October 1999
A year-long study comparing the effects of the three approved drugs formultiple sclerosis - Teva's Copaxone (glatiramer acetate), Berlex/Schering ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
